SCHEMBL7575596

SCHEMBL7575596

[CH2]CN1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.64
ALDH1A1 P00352 3/20 0.60
HTR3E A5X5Y0 1/20 0.60
HTR3B O95264 1/20 0.60
HTR1D P28221 1/20 0.60
HTR2C P28335 1/20 0.60
HTR3A P46098 1/20 0.60
HTR3D Q70Z44 1/20 0.60
HTR3C Q8WXA8 1/20 0.60
KDM4E B2RXH2 5/20 0.60
MAPT P10636 3/20 0.60
CYP1A2 P05177 2/20 0.60
CYP3A4 P08684 2/20 0.60
CYP2D6 P10635 2/20 0.60
CYP2C19 P33261 2/20 0.60
TSHR P16473 2/20 0.60
TDP1 Q9NUW8 2/20 0.60
NFKB1 P19838 1/20 0.60
MAPK1 P28482 1/20 0.60
THPO P40225 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2095954 0.88 SIGMAR1 (0.69) SIGMAR1ALDH1A1HTR3EHTR3BHTR1D
SCHEMBL28226906 0.87 ALDH1A1 (0.77) SIGMAR1ALDH1A1HTR3EHTR3BHTR1D
SCHEMBL2090542 0.85 SIGMAR1 (0.69) SIGMAR1ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL8159579 0.84 SIGMAR1 (0.64) SIGMAR1ALDH1A1HTR3EHTR3BHTR1D
SCHEMBL6926448 0.84 SIGMAR1 (0.64) SIGMAR1ALDH1A1HTR3EHTR3BHTR1D
SCHEMBL11465528 0.84 SIGMAR1 (0.76) SIGMAR1ALDH1A1HTR3EHTR3BHTR1D
SCHEMBL2090423 0.84 SIGMAR1 (0.71) SIGMAR1ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL8577276 0.84 SIGMAR1 (0.60) SIGMAR1ALDH1A1HTR3EHTR3BHTR1D
Hydrochloric Acid SCHEMBL10997933 0.82 SIGMAR1 (0.59) SIGMAR1ALDH1A1HTR3EHTR3BHTR1D
SCHEMBL7295918 0.82 ALDH1A1 (0.66) SIGMAR1ALDH1A1HTR3EHTR3BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5200408-A Urea or thiourea derivatives; pain treatment LABORATOIRES UPSA (FR) 1993-04-06 US claimed
EP-0195374-B1 N-SUBSTITUTED 3,4-DIHYDROPYRIMIDINE DERIVATIVES, PROCESS FOR THE PRODUCTION THEREOF AND COMPOSITION CONTAINING SAME FOR TREATING DISORDERS OF CARDIOVASCULAR SYSTEM SUNTORY LIMITED (JP) 1992-07-29 EP claimed
CN-102125557-A Use of flibanserin in the treatment of sexual disorders BOEHRINGER INGELHEIM PHARMA 2011-07-20 CN disclosed
CN-102058597-A Use of flibanserin in the treatment of sexual disorders BOEHRINGER INGELHEIM PHARMA 2011-05-18 CN disclosed
CN-101347431-A Use of flibanserin in the treatment of sexual disorders BOEHRINGER INGELHEIM PHARMA (DE) 2009-01-21 CN disclosed
CN-1946404-A Pharmaceutical compositions for the treatment of sexual disorders II BOEHRINGER INGELHEIM PHARMA (DE) 2007-04-11 CN disclosed
CN-1571670-A Use of flibanserin in the treatment of sexual disorders BOEHRINGER INGELHEIM PHARMA (DE) 2005-01-26 CN disclosed
WO-2002092088-A2 NOVEL USE OF 2H-BENZIMIDAZOL-2-ONE, 1,3-DIHADRO-1-(2{4-{3-(TRIFLUOROMETHYL}PHENYL]-1-PIPERAZINYL}ETHYL)- AND ITS PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS BECK JUERGEN K (DE) 2002-11-21 WO disclosed
US-5200408-A Urea or thiourea derivatives; pain treatment LABORATOIRES UPSA (FR) 1993-04-06 US disclosed
EP-0195374-B1 N-SUBSTITUTED 3,4-DIHYDROPYRIMIDINE DERIVATIVES, PROCESS FOR THE PRODUCTION THEREOF AND COMPOSITION CONTAINING SAME FOR TREATING DISORDERS OF CARDIOVASCULAR SYSTEM SUNTORY LIMITED (JP) 1992-07-29 EP disclosed
US-4017623-A Esters of 2-[(4-quinolyl)amino]-benzoic acids in analgesic and anti-inflammatory compositions SYNTHELABO (FR) 1977-04-12 US disclosed